Obesity Treatment

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Zepbound is a prescription medication that should only be used under the supervision of a licensed healthcare provider. Always consult your doctor before starting or changing any medication. Zepbound arrived in late 2023 and pretty quickly became one of the most talked-about weight loss drugs on the market. It’s tirzepatide, the same active ingredient as Mounjaro, but approved specifically for chronic weight management rather than type 2 diabetes. The distinction matters because it affects insurance coverage, prescribing patterns, and how doctors talk about it with patients. ...

Introduction If you are considering medical treatment for obesity in 2026, two names dominate the conversation: Mounjaro (tirzepatide) and Wegovy (semaglutide). Both are once-weekly injectable medications that have transformed the landscape of weight management, producing results that were previously achievable only with bariatric surgery. But they are not interchangeable — they differ in their mechanism of action, the magnitude of weight loss they produce, their side effect profiles, their cardiovascular evidence base, and their cost. ...

If you’ve spent any time researching GLP-1 medications, you’ve probably wondered: what’s the actual difference between Wegovy and Ozempic? They’re both made by Novo Nordisk, both contain semaglutide, and both come in similar-looking injection pens. The answer matters because it affects what your doctor prescribes, what your insurance covers, and how much you pay. Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication. ...